COLLABORATION AGREEMENT AMENDMENT NUMBER THREECollaboration Agreement • September 19th, 2011 • Transition Therapeutics Inc. • Medicinal chemicals & botanical products
THIS COLLABORATION AGREEMENT AMENDMENT NUMBER THREE (the “Amendment”) is effective as of December 26, 2010 (“Amendment Effective Date”) by and between Waratah Pharmaceuticals Inc., a company with offices at Suite 220, 101 College Street, Toronto, Ontario, M5G 1L7 (“Waratah”) and Elan Pharma International Limited, a private company limited by shares organized under the laws of Ireland with offices at Monksland, Athlone, County Westmeath, Ireland (“Elan”).
